Holen Sie sich die Stockscreener-App
0.7802
2.66%
-0.0213
Schlusskurs vom Vortag:
$0.8015
Offen:
$0.81
24-Stunden-Volumen:
82,041
Relative Volume:
0.28
Marktkapitalisierung:
$59.96M
Einnahmen:
$9.53M
Nettoeinkommen (Verlust:
$-44.61M
KGV:
-0.8574
EPS:
-0.91
Netto-Cashflow:
$-38.32M
1W Leistung:
-5.54%
1M Leistung:
-4.89%
6M Leistung:
-37.08%
1J Leistung:
+8.21%
1-Tages-Spanne:
$0.78
$0.81
1-Wochen-Bereich:
$0.78
$0.8873
52-Wochen-Spanne:
$0.45
$1.9891
Cue Biopharma Inc Stock (CUE) Company Profile
Firmenname
Cue Biopharma Inc
Sektor
Branche
Telefon
617-949-2680
Adresse
40 GUEST STREET, BOSTON, MA
Vergleichen Sie CUE mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
CUE
Cue Biopharma Inc
|
0.7802 | 61.59M | 9.53M | -44.61M | -38.32M | -0.91 |
|
VRTX
Vertex Pharmaceuticals Inc
|
391.02 | 100.52B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
580.70 | 61.43B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
446.51 | 59.29B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
712.20 | 43.09B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
306.05 | 35.42B | 3.81B | -644.79M | -669.77M | -6.24 |
Cue Biopharma Inc Stock (CUE) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-03-13 | Eingeleitet | Jefferies | Buy |
| 2023-06-26 | Fortgesetzt | Oppenheimer | Outperform |
| 2022-11-21 | Eingeleitet | Piper Sandler | Overweight |
| 2022-01-13 | Eingeleitet | H.C. Wainwright | Buy |
| 2022-01-03 | Eingeleitet | Craig Hallum | Buy |
| 2020-11-24 | Eingeleitet | Berenberg | Buy |
| 2020-04-09 | Eingeleitet | Stifel | Buy |
| 2020-01-28 | Eingeleitet | BTIG Research | Buy |
| 2020-01-22 | Eingeleitet | JMP Securities | Mkt Outperform |
Alle ansehen
Cue Biopharma Inc Aktie (CUE) Neueste Nachrichten
Will Cue Biopharma Inc. benefit from macro trendsJuly 2025 Outlook & Stepwise Trade Signal Implementation - Newser
Key resistance and support levels for Cue Biopharma Inc.July 2025 Chart Watch & Advanced Technical Analysis Signals - Newser
Can Cue Biopharma Inc. rally from current levelsOil Prices & Weekly Top Gainers Trade List - Newser
Is Cue Biopharma Inc. stock entering bullish territoryTrade Analysis Summary & Real-Time Market Sentiment Alerts - Newser
Why Cue Biopharma Inc. stock is on top investor watchlistsJuly 2025 EndofMonth & Safe Capital Growth Tips - Newser
Cue Biopharma Inc. stock trend forecastJuly 2025 Technicals & AI Driven Price Forecasts - Newser
Will Cue Biopharma Inc. stock benefit from interest rate changes2025 Market Overview & Safe Entry Point Identification - Newser
Real time alert setup for Cue Biopharma Inc. performancePortfolio Return Summary & AI Powered Trade Plan Recommendations - Newser
Does Cue Biopharma Inc. fit your quant trading modelWeekly Profit Analysis & Community Verified Watchlist Alerts - Newser
Analyzing recovery setups for Cue Biopharma Inc. investorsEarnings Recap Summary & Consistent Return Investment Signals - Newser
Can Cue Biopharma Inc. disrupt its industryWeekly Stock Report & Entry Point Confirmation Signals - sundaytimes.kr
How Cue Biopharma Inc. stock performs during market volatilityWeekly Trend Recap & Technical Analysis for Trade Confirmation - Newser
Will Cue Biopharma Inc. bounce back from current supportDollar Strength & Growth Focused Investment Plans - Newser
How hedge fund analytics apply to Cue Biopharma Inc. stockJuly 2025 Fed Impact & Daily Chart Pattern Signal Reports - Newser
Regression analysis insights on Cue Biopharma Inc. performanceBond Market & Growth-Oriented Investment Plans - Newser
What makes Cue Biopharma Inc. stock price move sharplyWeekly Trade Review & Verified Technical Signals - Newser
Earnings visualization tools for Cue Biopharma Inc.Weekly Gains Summary & Detailed Earnings Play Strategies - Newser
Is Cue Biopharma Inc. meeting your algorithmic filter criteriaWeekly Profit Report & Weekly Consistent Profit Watchlists - Newser
Does Cue Biopharma Inc. meet Warren Buffett’s criteriaWeekly Market Report & Weekly Return Optimization Alerts - sundaytimes.kr
Short Term Charts Align With Long Term Uptrend in Cue Biopharma Inc. getLinesFromResByArray error: size == 0 - thegnnews.com
Real time scanner hits for Cue Biopharma Inc. explainedEarnings Performance Report & Safe Capital Growth Trade Ideas - Newser
Leading vs lagging indicators on Cue Biopharma Inc. performance2025 Trading Volume Trends & Entry Point Confirmation Signals - Newser
Has Cue Biopharma Inc. found a price floorJuly 2025 Sentiment & Fast Gain Swing Trade Alerts - Newser
Finanzdaten der Cue Biopharma Inc-Aktie (CUE)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.96%
1.09%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):